Overview

Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects

Status:
Completed
Trial end date:
2018-05-25
Target enrollment:
Participant gender:
Summary
This study will be conducted to evaluate the pharmacokinetics of perampanel following single and multiple oral doses in Chinese healthy male and female participants.
Phase:
Phase 1
Details
Lead Sponsor:
Eisai Co., Ltd.